Cena / výnosy společnosti AMAG Pharmaceuticals
Jaká je hodnota metriky Cena / výnosy společnosti AMAG Pharmaceuticals?
Hodnota metriky Cena / výnosy společnosti AMAG Pharmaceuticals, Inc. je 1.57
Jaká je definice metriky Cena / výnosy?
Cena / výnosy (Price to sales ratio) je ukazatel,který představuje cenu společnosti ve srovnání s výškou její tržeb.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Cena / výnosy společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností AMAG Pharmaceuticals
Čemu se věnuje společnost AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Firmy s metrikou cena / výnosy podobnou společnosti AMAG Pharmaceuticals
- Hodnota metriky Cena / výnosy společnosti Louisiana-Pacific je 1.57
- Hodnota metriky Cena / výnosy společnosti Voyager Therapeutics Inc je 1.57
- Hodnota metriky Cena / výnosy společnosti SoFi Technologies je 1.57
- Hodnota metriky Cena / výnosy společnosti Colfax Corp je 1.57
- Hodnota metriky Cena / výnosy společnosti Chevron je 1.57
- Hodnota metriky Cena / výnosy společnosti Seagate Technology plc je 1.57
- Hodnota metriky Cena / výnosy společnosti AMAG Pharmaceuticals je 1.57
- Hodnota metriky Cena / výnosy společnosti Rexnord Electronics and Controls je 1.57
- Hodnota metriky Cena / výnosy společnosti Xponential Fitness je 1.57
- Hodnota metriky Cena / výnosy společnosti Religare Enterprises je 1.57
- Hodnota metriky Cena / výnosy společnosti Aviva Plc je 1.57
- Hodnota metriky Cena / výnosy společnosti Atul Auto je 1.57
- Hodnota metriky Cena / výnosy společnosti The South Indian Bank je 1.57